Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Epstein-Barr Virus Infections × Granulocyte Colony-Stimulating Factor × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 18 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Myelodysplastic Syndromes 8 Leukemia, Biphenotypic, Acute 6 Burkitt Lymphoma 5 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Hodgkin Disease 4 Recurrence 3 Multiple Myeloma 3 Lymphoma, Large B-Cell, Diffuse 3 Hematologic Neoplasms 3 Breast Neoplasms 3 Myeloproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma 2 Leukemia, Myelomonocytic, Chronic 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Anemia, Refractory, with Excess of Blasts 2 Teratoma 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Primary Myelofibrosis 1 Osteosarcoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1

Interventions

pomalidomide 1 dehydroftorafur 1 brincidofovir 1 Watchful Waiting 1 Vincristine 1 Taxes 1 Rituximab 1 Radiotherapy, Intensity-Modulated 1 Prednisone 1 Platinum 1 Paclitaxel 1 Nivolumab 1 Gemcitabine 1 Fluorouracil 1 Etoposide 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 1,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡